The IPilogue is IP Osgoode’s online journal of IP Law and Technology. It publishes analysis and commentary on current pressing intellectual property, technology, privacy and related legal issues. The IPilogue features curated contributions from students, scholars, and experts within the Osgoode community, from our network of affiliated researchers and partners, as well as from professionals and scholars in disciplines outside of law.
Editor in Chief: Prof. Carys Craig (ccraig@osgoode.yorku.ca)
Submission inquiries: iposgoode@osgoode.yorku.ca
2016 was a winning year for Western trademarks in China. It produced an unprecedented number of decisions – two, to be exact – in which China won praise for protecting foreign trademarks, affirming intellectual property rights, and developing a friendlier environment for international businesses. The only loser was trademark law itself, as the two decisions […]
Like it or not, some people spend a lot of money on art. When they do, art buyers are likely unhappy when they get something other than they bargained for. Modern forgeries are a thorn in the side of fine art buyers, sellers, and scholars.
As part of the IP Osgoode Speaks Series, Dr. Siva Thambisetty, an associate professor of law at the London School of Economics, visited Osgoode Hall Law School to speak on the subject of patent dialect. The main focus of her talk, entitled, "Is Patent Law Evasive or Merely Elusive?", was to highlight the issue of […]
The Intellectual Property Institute of Canada (IPIC) and IP Osgoode are delighted to announce our 2017 Canadian writing challenge in intellectual property law.
As ratification stutters for the Comprehensive Economic and Trade Agreement (CETA), the much-maligned free-trade deal between Canada and the European Union, debate continues as to whether the Canadian intellectual property (IP) regime will provide adequate protection for innovative biologic medicines in relation to subsequent-entry biologics (SEBs). Biologic medicines are complex molecules derived from living organisms […]
Yes, it is apparently possible – Elsevier just did it. Elsevier is one of the largest science and medical publishers in the world. Prestigious journals, such as Cell and The Lancet, are amongst its products. Over the years, it has been the subject of a number of criticisms, including its pricing regime (see here, here […]
On September 14, the European Commission published draft legislation aimed at modernising the European copyright framework. To ensure the draft legislation delivers the best outcomes for all those affected by it, the Intellectual Property Office made a call for views on the costs and benefits of the proposed measures, and suggestions for how the language […]
What happens when intellectual property law collides with the social sciences? They meld together for some fascinating experiments. In a lecture given at Osgoode Hall Law School as part of the IP Osgoode Speaks Series, Prof. Chris Buccafusco described three such experiments performed by him and his team.[1] Specifically, their research seeks to develop an […]
The distinction between combinations and aggregations is a well-accepted principle of patent law. A combination is an assemblage of known elements whose combined use leads to a result that is different from the sum of the results of the individual elements. Whereas, an aggregation is an assemblage of elements that each produce their expected result […]
Earlier this month, Osgoode Hall Law School welcomed Amy Adler, New York University’s Emily Kempin Professor of Law, to present on copyright and the future of art. Professor Adler is a leading scholar of art law and specializes in the legal regulation of artistic expression, sexuality and free speech. Visual artists today, as she describes, […]